Back to Gastroenterology
Gastroenterologyv2002Evidence-Based

MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)

Quantifies end-stage liver disease for transplant planning using the original pre-2016 formula without sodium

Clinical Input Parameters

mg/dL
Range: 0.01 — 40 mg/dL
mg/dL
Range: 1e-8 — 50 mg/dL
Range: 0.1 — 20
Clinical Assessment
Awaiting Parameters
meld score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

MELD = (0.957 × ln(Cr) + 0.378 × ln(bilirubin) + 1.120 × ln(INR) + 0.643) × 10

Clinical Pearls & Practice Notes

  • This is the original pre-2016 MELD formula without sodium
  • For patients on hemodialysis, creatinine value is set to 4.0
  • Laboratory values less than 1.0 are set to 1.0 for calculation
  • Values should be no more than 48 hours old
  • Final score is rounded to nearest whole number and bounded between 6-40
  • Replaced by MELD-Na in 2016 for UNOS allocation

Evidence & Literature Citations

  1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.
  2. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003 Jan;124(1):91-6. doi: 10.1053/gast.2003.50016.
  3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000 Apr;31(4):864-71. doi: 10.1053/he.2000.5852.

Score Interpretation Ranges

Low Risk6 – 9 pts

MELD ≤9

Moderate Risk10 – 19 pts

MELD 10-19

High Risk20 – 29 pts

MELD 20-29

Very High Risk30 – 39 pts

MELD 30-39

Extremely High Risk40 – 40 pts

MELD ≥40

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.